Published in:
01-10-2014 | Benign Prostatic Hyperplasia (K McVary, Section Editor)
Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
Authors:
Charles Welliver, Michael Butcher, Yogitha Potini, Kevin T. McVary
Published in:
Current Urology Reports
|
Issue 10/2014
Login to get access
Abstract
Medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia are frequently associated with changes in sexual function. While these medications are generally well-tolerated and have both reduced and delayed more invasive surgical options, the ramifications of long-term chronic use are largely unknown. Sexual side effects of these medications are frequently either reported as part of a short-term initial drug study or have inflexible endpoints that are not able to gauge more subtle changes in sexual performance. This review will delineate the currently known effects of these medications on sexual function and will consider mechanisms of dysfunction.